Shionogi & Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shionogi & Co Ltd with three other
companies in this sector in Japan:
Mitsubishi Tanabe Pharma Corp
sales of 423.98 billion Japanese Yen [US$3.96 billion]
of which 74%
was Domestic Ethical Drug),
Kyowa Hakko Kirin Company Limited
(353.38 billion Japanese Yen [US$3.30 billion]
of which 78%
was Pharmaceutical Business), and
Taisho Pharmaceutical Holdings Co Ltd
(279.77 billion Japanese Yen [US$2.61 billion]
of which 64%
During the year ended March of 2017, sales at
Shionogi & Co Ltd were ¥338.89 billion (US$3.16 billion).
increase of 9.3%
versus 2016, when the company's sales were ¥309.97 billion.